RGEN

#3722
Repligen Corporation - Common Stock
1.2 4 USD
-98.99%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.24
1.24
Faixa anual
1.12
175.57
Mudança diária
-98.99%
Mudança mensal
-98.91%
Mudança em 6 meses
-99.26%
Mudança anual
-99.25%
Fechamento anterior
122.7 3
Open
1.2 4
Mínimo
1.2 4
High
1.2 4
Volume
154
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 69.92 M
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Instrumentos médicos e consumíveis
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
190.53
Índice preço/fluxo de caixa
0.01

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Notícias